Avelar RA, Ortega JG, Tacutu R, Tyler EJ, Bennett D, Binetti P, Budovsky A, Chatsirisupachai K, Johnson E, Murray A, Shields S, Tejada-Martinez D, Thornton D, Fraifeld VE, Bishop CL, de Magalhães JP (2020) A multidimensional systems biology analysis of cellular senescence in aging and disease. Genome Biol 21(1):91. https://doi.org/10.1186/s13059-020-01990-9
Article CAS PubMed Central PubMed Google Scholar
Bergmann J, Müller M, Baumann N, Reichert M, Heneweer C, Bolik J, Lücke K, Gruber S, Carambia A, Boretius S, Leuschner I, Becker T, Rabe B, Herkel J, Wunderlich FT, Mittrücker H-W, Rose-John S, Schmidt-Arras D (2017) IL-6 trans-signaling is essential for the development of hepatocellular carcinoma in mice. Hepatology (Baltimore MD) 65(1). https://doi.org/10.1002/hep.28874
Bloom SI, Islam MT, Lesniewski LA, Donato AJ (2023) Mechanisms and consequences of endothelial cell senescence. Nat Rev Cardiol 20(1):38–51. https://doi.org/10.1038/s41569-022-00739-0
Cai N, Cheng K, Ma Y, Liu S, Tao R, Li Y, Li D, Guo B, Jia W, Liang H, Zhao J, Xia L, Ding Z-Y, Chen J, Zhang W (2023) Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8 + T cell-mediated antitumour immunity and improves anti-PD-1 efficacy. Gut. https://doi.org/10.1136/gutjnl-2023-331342
Campisi J (2013) Aging, cellular senescence, and cancer. Annu Rev Physiol 75:685–705. https://doi.org/10.1146/annurev-physiol-030212-183653
Article CAS PubMed Google Scholar
Cao Z, Scandura JM, Inghirami GG, Shido K, Ding B-S, Rafii S (2017) Molecular checkpoint decisions made by subverted vascular niche transform indolent tumor cells into Chemoresistant Cancer Stem cells. Cancer Cell 31(1):110–126. https://doi.org/10.1016/j.ccell.2016.11.010
Article CAS PubMed Google Scholar
Childs BG, Baker DJ, Wijshake T, Conover CA, Campisi J, van Deursen JM (2016) Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science 354(6311):472–477
Article CAS PubMed Central PubMed Google Scholar
D’Ambrosio M, Gil J (2023) Reshaping of the tumor microenvironment by cellular senescence: an opportunity for senotherapies. Dev Cell 58(12):1007–1021. https://doi.org/10.1016/j.devcel.2023.05.010
Article CAS PubMed Google Scholar
Demaria M, O’Leary MN, Chang J, Shao L, Liu S, Alimirah F, Koenig K, Le C, Mitin N, Deal AM, Alston S, Academia EC, Kilmarx S, Valdovinos A, Wang B, de Bruin A, Kennedy BK, Melov S, Zhou D, Sharpless NE, Muss H, Campisi J (2017) Cellular Senescence promotes adverse effects of Chemotherapy and Cancer Relapse. Cancer Discov 7(2):165–176. https://doi.org/10.1158/2159-8290.CD-16-0241
Article CAS PubMed Google Scholar
Doedens AL, Phan AT, Stradner MH, Fujimoto JK, Nguyen JV, Yang E, Johnson RS, Goldrath AW (2013) Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen. Nat Immunol 14(11):1173–1182. https://doi.org/10.1038/ni.2714
Article CAS PubMed Central PubMed Google Scholar
Donne R, Lujambio A (2023) The liver cancer immune microenvironment: therapeutic implications for hepatocellular carcinoma. Hepatology (Baltimore MD) 77(5):1773–1796. https://doi.org/10.1002/hep.32740
Faget DV, Ren Q, Stewart SA (2019) Unmasking senescence: context-dependent effects of SASP in cancer. Nat Rev Cancer 19(8):439–453. https://doi.org/10.1038/s41568-019-0156-2
Article CAS PubMed Google Scholar
Franco F, Jaccard A, Romero P, Yu Y-R, Ho P-C (2020) Metabolic and epigenetic regulation of T-cell exhaustion. Nat Metabolism 2(10):1001–1012. https://doi.org/10.1038/s42255-020-00280-9
Garcia J, Hurwitz HI, Sandler AB, Miles D, Coleman RL, Deurloo R, Chinot OL (2020) Bevacizumab (Avastin®) in cancer treatment: a review of 15 years of clinical experience and future outlook. Cancer Treat Rev 86:102017. https://doi.org/10.1016/j.ctrv.2020.102017
Article CAS PubMed Google Scholar
Hailemichael Y, Johnson DH, Abdel-Wahab N, Foo WC, Bentebibel S-E, Daher M, Haymaker C, Wani K, Saberian C, Ogata D, Kim ST, Nurieva R, Lazar AJ, Abu-Sbeih H, Fa’ak F, Mathew A, Wang Y, Falohun A, Trinh V, Zobniw C, Spillson C, Burks JK, Awiwi M, Elsayes K, Soto LS, Melendez BD, Davies MA, Wargo J, Curry J, Yee C, Lizee G, Singh S, Sharma P, Allison JP, Hwu P, Ekmekcioglu S, Diab A (2022) Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity. Cancer Cell 40(5). https://doi.org/10.1016/j.ccell.2022.04.004
Hamidi H, Ivaska J (2018) Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer 18(9):533–548. https://doi.org/10.1038/s41568-018-0038-z
Article CAS PubMed Central PubMed Google Scholar
Hanahan D (2022) Hallmarks of Cancer: New dimensions. Cancer Discov 12(1):31–46. https://doi.org/10.1158/2159-8290.CD-21-1059
Article CAS PubMed Google Scholar
He Q, Liu M, Huang W, Chen X, Zhang B, Zhang T, Wang Y, Liu D, Xie M, Ji X, Sun M, Tian D, Xia L (2021) IL-1β-Induced Elevation of Solute Carrier Family 7 Member 11 promotes Hepatocellular Carcinoma Metastasis through Up-regulating programmed death Ligand 1 and colony-stimulating factor 1. Hepatology (Baltimore MD) 74(6):3174–3193. https://doi.org/10.1002/hep.32062
Article CAS PubMed Google Scholar
Honda S, Ikeda K, Urata R, Yamazaki E, Emoto N, Matoba S (2021) Cellular senescence promotes endothelial activation through epigenetic alteration, and consequently accelerates atherosclerosis. Sci Rep 11(1):14608. https://doi.org/10.1038/s41598-021-94097-5
Article CAS PubMed Central PubMed Google Scholar
Hu W, Zheng S, Guo H, Dai B, Ni J, Shi Y, Bian H, Li L, Shen Y, Wu M, Tian Z, Liu G, Hossain MA, Yang H, Wang D, Zhang Q, Yu J, Birnbaumer L, Feng J, Yu D, Yang Y (2021) PLAGL2-EGFR-HIF-1/2α signaling Loop promotes HCC Progression and Erlotinib Insensitivity. Hepatology (Baltimore MD) 73(2):674–691. https://doi.org/10.1002/hep.31293
Article CAS PubMed Google Scholar
Huynh KN, Rao S, Roth B, Bryan T, Fernando DM, Dayyani F, Imagawa D, Abi-Jaoudeh N (2023) Targeting hypoxia-inducible Factor-1α for the management of Hepatocellular Carcinoma. Cancers 15(10). https://doi.org/10.3390/cancers15102738
Hwang HJ, Lee Y-R, Kang D, Lee HC, Seo HR, Ryu J-K, Kim Y-N, Ko Y-G, Park HJ, Lee J-S (2020) Endothelial cells under therapy-induced senescence secrete CXCL11, which increases aggressiveness of breast cancer cells. Cancer Lett 490:100–110. https://doi.org/10.1016/j.canlet.2020.06.019
Article CAS PubMed Google Scholar
Jayson GC, Kerbel R, Ellis LM, Harris AL (2016) Antiangiogenic therapy in oncology: current status and future directions. Lancet 388(10043):518–529. https://doi.org/10.1016/S0140-6736(15)01088-0
Article CAS PubMed Google Scholar
Karges J, Kuang S, Maschietto F, Blacque O, Ciofini I, Chao H, Gasser G (2020) Rationally designed ruthenium complexes for 1- and 2-photon photodynamic therapy. Nat Commun 11(1):3262. https://doi.org/10.1038/s41467-020-16993-0
Article CAS PubMed Central PubMed Google Scholar
Lafargue A, Degorre C, Corre I, Alves-Guerra M-C, Gaugler M-H, Vallette F, Pecqueur C, Paris F (2017) Ionizing radiation induces long-term senescence in endothelial cells through mitochondrial respiratory complex II dysfunction and superoxide generation. Free Radic Biol Med 108:750–759. https://doi.org/10.1016/j.freeradbiomed.2017.04.019
Article CAS PubMed Google Scholar
Li F, Huangyang P, Burrows M, Guo K, Riscal R, Godfrey J, Lee KE, Lin N, Lee P, Blair IA, Keith B, Li B, Simon MC (2020) FBP1 loss disrupts liver metabolism and promotes tumorigenesis through a hepatic stellate cell senescence secretome. Nat Cell Biol 22(6):728–739. https://doi.org/10.1038/s41556-020-0511-2
Article CAS PubMed Central PubMed Google Scholar
Loo TM, Kamachi F, Watanabe Y, Yoshimoto S, Kanda H, Arai Y, Nakajima-Takagi Y, Iwama A, Koga T, Sugimoto Y, Ozawa T, Nakamura M, Kumagai M, Watashi K, Taketo MM, Aoki T, Narumiya S, Oshima M, Arita M, Hara E, Ohtani N (2017) Gut microbiota promotes obesity-Associated Liver Cancer through PGE2-Mediated suppression of Antitumor Immunity. Cancer Discov 7(5):522–538. https://doi.org/10.1158/2159-8290.CD-16-0932
Article CAS PubMed Google Scholar
Lu Y, Yang A, Quan C, Pan Y, Zhang H, Li Y, Gao C, Lu H, Wang X, Cao P, Chen H, Lu S, Zhou G (2022) A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma. Nat Commun 13(1):4594. https://doi.org/10.1038/s41467-022-32283-3
留言 (0)